Drawing based on the label description. No photo yet.
“The 300 mg/25 mg tablet is light red speckled, modified oval biconvex tablet, debossed with product identification "54 268" on one side and plain on the other side”
54 268 pill
Pill with imprint 54 268 is red, oval, 9 mm and has been identified as Irbesartan and Hydrochlorothiazide 300 mg / 25 mg. It is used for high blood pressure. It is supplied by Hikma Pharmaceuticals USA Inc.
Irbesartan and Hydrochlorothiazide 300 mg / 25 mg
- Imprint
- 54 268
- Strength
- Irbesartan 300 mg / Hydrochlorothiazide 25 mg
- Used for
- High blood pressure
- Color
- Red
- Shape
- Oval
- Size
- 9 mm
- Score
- No score line
- Form
- Tablet
- Manufacturer
- Hikma Pharmaceuticals USA Inc
- Drug class
- ARB (blood pressure medicine)
- NDC
- 0054-0256, 0054-0256-13, 0054-0256-22, 0054-0256-29
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Irbesartan and Hydrochlorothiazide used for?
Irbesartan and Hydrochlorothiazide is used for high blood pressure.
- Medicine type
- ARB (blood pressure medicine); thiazide diuretic (water pill)
Official uses from the US prescribing label
Irbesartan and hydrochlorothiazide tablets are indicated for the treatment of hypertension.
Irbesartan and hydrochlorothiazide tablets may be used in patients whose blood pressure is not adequately controlled on monotherapy.
Irbesartan and hydrochlorothiazide tablets may also be used as initial therapy in patients who are likely to need multiple drugs to achieve their blood pressure goals.
The choice of irbesartan and hydrochlorothiazide tablets as initial therapy for hypertension should be based on an assessment of potential benefits and risks.
Patients with stage 2 (moderate or severe) hypertension are at relatively high risk for cardiovascular events (such as strokes, heart attacks, and heart failure), kidney failure, and vision problems, so prompt treatment is clinically relevant. The decision to use a combination as initial therapy should be individualized and may be shaped by considerations such as the baseline blood pressure, the target goal, and the incremental likelihood of achieving goal with a combination compared with monotherapy.
Data from Studies V and VI provide estimates of the probability of reaching a blood pressure goal with irbesartan and hydrochlorothiazide tablets compared to irbesartan or hydrochlorothiazide (HCTZ) monotherapy. The relationship between baseline blood pressure and achievement of a SeSBP <140 or <130 mmHg or SeDBP <90 or <80 mmHg in patients treated with irbesartan and hydrochlorothiazide tablets compared to patients treated with irbesartan or HCTZ monotherapy are shown in Figures 1a through 2b.
*For all probability curves, patients without blood pressure measurements at Week 7 (Study VI) and Week 8 (Study V) were counted as not reaching goal (intent-to-treat analysis).
The above graphs provide a rough approximation of the likelihood of reaching a targeted blood pressure goal (e.g., Week 8 sitting systolic blood pressure ≤140 mmHg) for the treatment groups. The curve of each treatment group in each study was estimated by logistic regression modeling from all available data of that treatment group. The estimated likelihood at the right tail of each curve is less reliable due to small numbers of subjects with high baseline blood pressures.
For example, a patient with a blood pressure of 180/105 mmHg has about a 25% likelihood of achieving a goal of <140 mmHg (systolic) and 50% likelihood of achieving <90 mmHg (diastolic) on irbesartan alone (and lower still likelihoods on HCTZ alone).
The likelihood of achieving these goals on irbesartan and hydrochlorothiazide tablets rises to about 40% (systolic) or 70% (diastolic).
From the FDA-approved label on DailyMed (published Jul 08, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- One side shows 54 268 and the other side is plain.
- It is red, oval, 9 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
According to its label, this product is no longer being made or sold.
Ingredients
Active: Irbesartan, Hydrochlorothiazide
Inactive: Lactose Monohydrate, Croscarmellose Sodium, Magnesium Stearate, Silicon Dioxide, Ferric Oxide Red, Povidone K25, Microcrystalline Cellulose
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
711
Mesalamine 1.2 g
Red, oval, 10 mm
Used for ulcerative colitis and proctitis
- F18 Nerandomilast 18 mg Red, oval, 10 mm Used for idiopathic pulmonary fibrosis
- A9 Ferrous Fumarate Red, oval, 9 mm
- GSI 10 Ambrisentan 10 mg Red, oval, 10 mm Used for high blood pressure in the lungs
- WC Ferrous Fumarate Red, oval, 8 mm
- TLZ 010 Talazoparib 0.1 mg Red, oval, 9 mm Used for breast cancer
Other Irbesartan and Hydrochlorothiazide pills
- 150H Hydrochlorothiazide and Irbesartan 12.5 mg / 150 mg Orange, oval Used for high blood pressure
- 150H Hydrochlorothiazide and Irbesartan 12.5 mg / 150 mg Orange, oval Used for high blood pressure
- 150H Hydrochlorothiazide and Irbesartan 12.5 mg / 150 mg Orange, oval Used for high blood pressure
- 300H Hydrochlorothiazide and Irbesartan 12.5 mg / 300 mg Orange, oval Used for high blood pressure
- 300H Hydrochlorothiazide and Irbesartan 12.5 mg / 300 mg Orange, oval Used for high blood pressure
- rph I31 Hydrochlorothiazide and Irbesartan 25 mg / 300 mg Brown, oval Used for high blood pressure
- 300 Hydrochlorothiazide and Irbesartan 25 mg / 300 mg Pink, oval Used for high blood pressure
- 300 Hydrochlorothiazide and Irbesartan 25 mg / 300 mg Pink, oval Used for high blood pressure